Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gay

Showing results (311-320 of 391) with videos related to

Pageof 40
Sort By:
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
Signal Transduction and Targeted Therapy|October 4, 2022
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancerYanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapiesJ S Ross, L M Gay, K Wang, et al.
The Oncologist|May 13, 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsLaurie M Gay, Sungeun Kim, Kyle Fedorchak, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung CancerKavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Molecular Cancer|December 2, 2025
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.
Cancer Research|December 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized TreatmentsKristiina Boettiger, Ildikó Kovács, Lilla Horvath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLCTriparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
Pageof 40

Showing results (311-320 of 391) with videos related to

Sort By:
Pageof 40
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
Signal Transduction and Targeted Therapy|October 4, 2022
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancerYanhua Tian, Qingqing Li, Zhenlin Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapiesJ S Ross, L M Gay, K Wang, et al.
The Oncologist|May 13, 2017
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsLaurie M Gay, Sungeun Kim, Kyle Fedorchak, et al.
Gynecologic Oncology|April 17, 2019
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapiesStéphanie L Gaillard, Kaitlyn J Andreano, Laurie M Gay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung CancerKavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte, et al.
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Molecular Cancer|December 2, 2025
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancerMingchao Xie, Miljenka Vuko, Shashank Saran, et al.
Cancer Research|December 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized TreatmentsKristiina Boettiger, Ildikó Kovács, Lilla Horvath, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLCTriparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
Pageof 40